IntriCon to be acquired by Altaris Capital affiliate for $241M
- Intricon (NASDAQ:IIN) has entered into a definitive agreement whereby an affiliate of Altaris Capital Partners, an investment firm focused exclusively on the healthcare industry, will acquire the company.
- Under the terms, Altaris will acquire all outstanding shares of Intricon for $24.25/share in a transaction that values Intricon at an equity value of ~$241M.
- The purchase price represents a meaningful premium of ~39% to Intricon’s closing stock price on Feb. 25, 2022.
- The transaction is expected to close in Q2 2022.
Recommended For You
Comments (1)
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

joezapp
28 Feb. 2022
Nice premium. Congratulations to IIN shareholders.